GBA Presents: RADIO SAVANT-!

Van... I am taking 1/2 GNRC off now with a $10 gain and keeping 1/2 for $220 target.>

No I do not use scanners! What are they going to tell me oh someone bought TSLA... please.

The whales are sunk. They have no blubber left to feed off.



Generac drops 10% to $133.37 after lowering FY22 revenue guidance :thumbsdown:

sell other half.:mad:
 
STOCK OF THE DAY- URANIUM ENERGY-

Uranium Energy price target raised to $8.25 from $7.25 at H.C. Wainwright 06:05 UEC H.C. Wainwright analyst Heiko Ihle raised the firm's price target on Uranium Energy to $8.25 from $7.25 and keeps a Buy rating on the shares following with the Roughrider acquisiotn complete.
 
FROM THE MAILROOM

Dear VZ (you stud you),

How did you do that so fast on P&G the moment it came out?

xxxoooo,
-Karen in Kansas
----------------------------------------
Dear Karen,
I used the old-school method of "refresh" on my web browser parked on PG's investor relation link and I knew that exact keyword to search for in the many pages that WS would be looking for.
"Organic Growth". It took 10 seconds and VZ beat the bots. :thumbsup:

Send a pic, and I'll call when I'm in Kansas next month.

-VZ

BUY PROCTOR AND GAMBLE
$128
Do it now
 



Watch S&P 3,700 for short squeeze potential, Citi says
Oct. 18, 2022
Investors should keep a watch on S&P 3,700 into the close, according to Citi.
Recommended For You
More Trending News
See More »
You’ve reached your free article limit
Want more?
We thought you might.
Navigating today’s market isn’t simple.
Special price for your first year
Only $119
 
Stoney!!!!!
QQQ down $2 and I'm making the children money hand over foot here.
Get ready for the bounce Stoney.
Write that down
MY $282 number is the level to get thru and hold for a few days... financial writers have taken note of my call Stoney! 150 likes already on TWTR this AM. :thumbsup::thumbsup::cool::cool::strong::strong:
 
Antero Resources initiated with a Buy at Jefferies 08:22 AR

Denbury initiated with a Buy at Jefferies

Moderna's Omicron booster has superior antibody response v. spikevax prototype

Abbott reports Q3 U.S. Medical Devices sales grew 11.3% 07:37 ABT U.S. Medical Devices sales grew 11.3% in the third quarter, led by strong double-digit growth in Electrophysiology, Structural Heart and Diabetes Care.

Elastic assumed with an Outperform at Baird » 07:12 ESTC
 
Back
Top